CD44 and cancer: The results obtained using CD44+/EpCAM+ double positive DU145 cancer stem cells concurred with the fact that bLf-Dox conjugates were more effective than Dox alone in reducing the aggressiveness of resistant cancer stem like cells by inhibiting their migration and tumour formation (Supplementary Information).